7111-0265 Screening compound: 2-[({1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}amino)methyl]-6-(prop-2-en-1-yl)phenol

7111-0265 Screening compound: 2-[({1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}amino)methyl]-6-(prop-2-en-1-yl)phenol
7111-0265 Screening compound: 2-[({1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}amino)methyl]-6-(prop-2-en-1-yl)phenol alternative view

Chemical Structure Depiction of ChemDiv screening compound 7111-0265
2-[({1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}amino)methyl]-6-(prop-2-en-1-yl)phenol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

7111-0265

Molecular Formula

C23H28N4O2 (C23 H28 N4 O2)

Compound Name

2-[({1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}amino)methyl]-6-(prop-2-en-1-yl)phenol

IUPAC name

2-[({1-[2-(morpholin-4-yl)ethyl]-1H-13-benzodiazol-2-yl}amino)methyl]-6-(prop-2-en-1-yl)phenol

SMILES

C=CCc1cccc(CNc2nc(cccc3)c3n2CCN2CCOCC2)c1O

InChI

InChI=1S/C23H28N4O2/c1-2-6-18-7-5-8-19(22(18)28)17-24-23-25-20-9-3-4-10-21(20)27(23)12-11-26-13-15-29-16-14-26/h2-5,7-10,28H,1,6,11-17H2,(H,24,25)

InChI Key

MPMCDQWHFDJOKI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05240089

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

392.5

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.939

Distribution Coefficient, logD

3.728

Water Solubility, LogSw

-3.92

Polar Surface Area

49.658

Acid Dissociation Constant (pKa)

11.19

Base Dissociation Constant (pKb)

7.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

7111-0265 in Drug Discovery

Included in Screening Libraries

Chelators targeting matrix metalloproteinases library (8930 compounds)

PI3K-Targeted Library (17255 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with 7111-0265 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 7111-0265?
Check Price and Availability of 7111-0265, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 7111-0265 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 7111-0265
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 7111-0265
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 7111-0265 available by request